M, L., S, R., J, M., Y, H., E, C., R, C., . . . Z, A. (2026). Distributional Cost-Effectiveness Analysis of Antenatal Lifestyle Interventions to Reduce the Incidence of Gestational Diabetes and Type-2 Diabetes. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 29(8), 1368. https://doi.org/10.1016/j.jval.2026.03.005
Chicago Style (17th ed.) CitationM, Lloyd, Rodda S, Morton J, Hu Y, Callander E, Cookson R, Teede H, and Ademi Z. "Distributional Cost-Effectiveness Analysis of Antenatal Lifestyle Interventions to Reduce the Incidence of Gestational Diabetes and Type-2 Diabetes." Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research 29, no. 8 (2026): 1368. https://doi.org/10.1016/j.jval.2026.03.005.
MLA (9th ed.) CitationM, Lloyd, et al. "Distributional Cost-Effectiveness Analysis of Antenatal Lifestyle Interventions to Reduce the Incidence of Gestational Diabetes and Type-2 Diabetes." Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 29, no. 8, 2026, p. 1368, https://doi.org/10.1016/j.jval.2026.03.005.